UT Soutwestern | Strategic Alliance Partners

Connect with us:

Latest from UT Soutwestern

Capitalizing on Cellular Therapies in Lymphoma and Myeloma

January 18, 2021

In our exclusive interview, Dr. Kansagra, Dr. D’Souza, and Dr. Dholaria provided an in-depth look into the current state of cellular therapy in hematologic malignancies, the benefits and drawbacks of approved and investigational products, and new constructs for CAR T in multiple myeloma and lymphoma.